Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Video

» Topical Discussion

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

October 8, 2019

Video

» Topical Discussion

STOPDAPT 2 HBR – Global Experts Panel Discussion

September 27, 2019

Video

» Topical Discussion

STOPDAPT 2 – Global Experts Discuss the Results and Implications of Landmark Short DAPT Study

June 6, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Stephan Windecker About Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Ken Kozuma About MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

September 27, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Ajay Kirtane About EVOLVE Short DAPT: A Single Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

September 29, 2019

Video

» Interview

ACC 2019: COBRA REDUCE Trial: Shortening DAPT Duration

March 21, 2019

Advertisement

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

STOPDAPT 2 HBR – Global Experts Panel Discussion

STOPDAPT 2 – Global Experts Discuss the Results and Implications of Landmark Short DAPT Study

Dr. C. Michael Gibson Talks With Dr. Stephan Windecker About Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Dr. C. Michael Gibson Talks With Dr. Ken Kozuma About MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Dr. C. Michael Gibson Talks With Dr. Ajay Kirtane About EVOLVE Short DAPT: A Single Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

ACC 2019: COBRA REDUCE Trial: Shortening DAPT Duration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content